Respiratorius is a research company focused on the development of drug candidates for the treatment of cancer and especially aggressive lymphoma. The company was originally established in 1999 as a spin-off from Lund University. The business is located in Sweden, where research is conducted in-house but also through international partners. The company is headquartered in Lund.

Quotes for Respiratorius AB

Right Now

+/-
-0.016
%
-3,72%
Latest
0.414
High
0.43
Low
0.4
Volume
431 714
Turnover (SEK)
176 305
Market Value (MSEK)
121,0
Time (Latest trade)

Board

CEO

  • Johan Drott

Chairperson of the Board

  • Niklas Prager

Board

  • Anna Törner
  • Kristina Drott
  • Peter Buhl

Videos

Largest Owners

Name Capital % Votes % Date
Christer Fåhraeus 11,24 11,24 2022-06-28
Avanza Pension 7,34 7,34 2022-06-28
Valcuria Holding AB 3,86 3,86 2022-06-28
Ben Hayes 2,34 2,34 2022-06-28
Hans Harvig 1,72 1,72 2022-06-28
Wilhelm Risberg 1,20 1,20 2022-06-28
Benny Bengtsson 1,20 1,20 2022-06-28
Formue Nord A/S 1,16 1,16 2022-06-28
Fredrik Lundgren 1,14 1,14 2022-06-28
Göran Lennart Rehn 0,99 0,99 2022-06-28
** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Insider trading

Key Numbers

*Compiled data from Millistream